PEA15
Astrocytic phosphoprotein PEA-15
Also known as: HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PEA15_HUMAN, PED, PED-PEA15, PED/PEA15
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15121
- Gene
- PEA15
- Ensembl
- ENSG00000162734
- Chromosome
- 1
- Canonical length
- 130 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles,Cytosol
OverviewNCBI Gene
This gene encodes a death effector domain-containing protein that functions as a negative regulator of apoptosis. The encoded protein is an endogenous substrate for protein kinase C. This protein is also overexpressed in type 2 diabetes mellitus, where it may contribute to insulin resistance in glucose uptake. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Canonical amino-acid sequenceUniProt
130 residues, UniProt reviewed canonical sequence.
>Q15121|PEA15
1 MAEYGTLLQD LTNNITLEDL EQLKSACKED IPSEKSEEIT TGSAWFSFLE SHNKLDKDNL
61 SYIEHIFEIS RRPDLLTMVV DYRTRVLKIS EEDELDTKLT RIPSAKKYKD IIRQPSEEEI
121 IKLAPPPKKALocalizationUniProt · AlphaFold · HPA
Whether an antibody against PEA15 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 1,946 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 1,946 nTPM
- midbrain: 957 nTPM
- amygdala: 873 nTPM
- cerebral cortex: 776 nTPM
- basal ganglia: 727 nTPM
- hypothalamus: 717 nTPM
Single-cell type
- esophageal apical cells: 544 nCPM
- müller glia: 208 nCPM
- hepatic stellate cells: 136 nCPM
- ocular epithelial cells: 126 nCPM
- cdc: 124 nCPM
- esophageal suprabasal cells: 122 nCPM
Immune cell
- intermediate monocyte: 78 nTPM
- myeloid DC: 57 nTPM
- classical monocyte: 39 nTPM
- non-classical monocyte: 39 nTPM
- plasmacytoid DC: 25 nTPM
- memory B-cell: 19 nTPM
Brain region
- white matter: 1,115 nTPM
- medulla oblongata: 975 nTPM
- midbrain: 949 nTPM
- hypothalamus: 799 nTPM
- spinal cord: 787 nTPM
- pons: 784 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.58
- gnomAD pLI
- 0.79
- gnomAD missense Z
- 2.24
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- MAPK cascade
- negative regulation of D-glucose import
- negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
- positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Death effector domain
- Death-like domain superfamily
- Death effector domain
- Astrocytic phosphoprotein PEA-15, death effector domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PEA15 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PEA15 as an antibody target. Whether an autoantibody or antibody against PEA15 could matter depends on whether native PEA15 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PEA15 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PEA15 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...